Rogerio Vivaldi

Bioverativ aims to keep parent Biogen's 'patient-centric' image

Biogen’s hemophilia spinoff, Bioverativ, is officially here. And while the company may be new, when it comes to corporate image, it plans to keep the old.

Carly Helfand Feb 1, 2017 9:58am